From: Damage effect of high-intensity focused ultrasound on breast cancer tissues and their vascularities
 | Control group (n = 25) | HIFU group (n = 25) | p value |
---|---|---|---|
Tumor size: mean (range) | 2.3~4.5 cm | 2.1~4.8 cm | p = NS |
Breast cancer TNM staging: n (%) | Â | ||
 Stage I | 7 (28.0 %) | 6 (24.0 %) | p = NS |
 Stage IIa | 5 (20.0 %) | 4 (16.0 %) |  |
 Stage IIb | 13 (52.0 %) | 15 (60.0 %) |  |
 Not reported | 0 (0.0 %) | 0 (0.0 %) |  |
Histopathologic grade | Â | ||
 G1 well differentiated | 12 (48.0 %) | 10 (40.0 %) | p = NS |
 G2 moderately differentiated | 9 (36.0 %) | 12 (48.0)% |  |
 G3 poorly differentiated | 4 (16.0 %) | 3 (12.0 %) |  |
Receptor status | Â | Â | Â |
 ER+/PR+ | 14 (56.0 %) | 13 (52.0 %) | p = NS |
 ER+/PR− | 2 (8.0 %) | 4 (16.0 %) |  |
 ER−/PR− | 8 (32.0 %) | 7 (28.0 %) |  |
Histological subtype | Â | ||
 Infiltrating ductal carcinoma | 14 (56.0 %) | 13 (52.0 %) | p = NS |
 Infiltrating lobular carcinoma | 5 (20.0 %) | 7 (28.0 %) |  |
 Other subtype | 6 (24.0 %) | 5 (20.0 %) |  |
Ipsilateral lymph node metastasis | Â | ||
 Sentinel lymph node biopsy | 10 (40.0 %) | 10 (40 %) | p = NS |
 Postoperative permanent pathology | 11 (44.0 %) | 12 (48 %) |  |
 Not reported | 0 (0.0 %) | 0 (0 %) |  |
Lesion location: side | Â | Â | Â |
 Left side | 12 (48.0 %) | 14 (56.0 %) | p = NS |
 Right side | 13 (52.0 %) | 11 (44.0 %) |  |
Lesion location: vertical | Â | ||
 Upper | 7 (28.0 %) | 9 (36.0 %) | p = NS |
 Lower | 11 (44.0 %) | 10 (40.0 %) |  |
 Midline | 7 (28.0 %) | 5 (20.0 %) |  |
Lesion location: horizontal | Â | ||
 Upper | 7 (28.0 %) | 9 (36.0 %) | p = NS |
 Lower | 11 (44.0 %) | 10 (40.0 %) |  |
 Midline | 7 (28.0 %) | 5 (20.0 %) |  |